871
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

The short-term improvements of enriched environment in behaviors and pathological changes of APP/PS1 mice via regulating cytokines

, , , , &
Pages 2003-2011 | Received 26 Jan 2018, Accepted 07 Apr 2018, Published online: 01 Jun 2018

References

  • 2016 Alzheimer's disease facts and figures. Alzheimers Dement. 2016;12(4):459–509.
  • Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, Jäggi F, Wolburg H, Gengler S, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep. 2006;7(9):940–6. doi:10.1038/sj.embor.7400784.
  • Hickman RA, Faustin A, Wisniewski T. Alzheimer disease and its growing epidemic: risk factors, biomarkers, and the urgent need for therapeutics. Neurol Clin. 2016 Nov;34(4):941–53.
  • Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011 Aug 19;10(9):698–712.
  • Mucke L, Selkoe DJ. Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006338.
  • Contestabile A. The history of the cholinergic hypothesis. Behav Brain Res. 2011 Aug 10;221(2):334–40.
  • Chakrabarti S, Khemka VK, Banerjee A, Chatterjee G, Ganguly A, Biswas A. Metabolic risk factors of sporadic alzheimer's disease: implications in the pathology, pathogenesis and treatment. Aging Dis. 2015 Aug 1;6(4):282–99. doi:10.14336/AD.2014.002.
  • Mendiola-Precoma J, Berumen LC, Padilla K, Garcia-Alcocer G. Therapies for prevention and treatment of alzheimer's disease. Biomed Res Int. 2016;2016:2589276. doi:10.1155/2016/2589276.
  • Laviola G, Hannan AJ, Macrì S, Solinas M, Jaber M. Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiol Dis. 2008 Aug;31(2):159–68. doi:10.1016/j.nbd.2008.05.001.
  • Jungling A, Reglodi D, Karadi ZN, Horvath G, Farkas J, Gaszner B, Tamas A. Effects of Postnatal Enriched Environment in a Model of Parkinson's Disease in Adult Rats. Int J Mol Sci. 2017 Feb 14;18(2):E406. doi:10.3390/ijms18020406.
  • Zhang J, Guo Y, Wang Y, Song L, Zhang R, Du Y. Long-term treadmill exercise attenuates Aβ burdens and astrocyte activation in APP/PS1 mouse model of Alzheimer's disease. Neurosci Lett. 2017; 666(13):70–77. doi:10.1016/j.neulet.2017.12.025.
  • Levi O, Michaelson DM. Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice. J Neurochem. 2007 Jan;100(1):202–10.
  • Jankowsky JL, Xu G, Fromholt D, Gonzales V, Borchelt DR. Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol. 2003 Dec;62(12):1220–7.
  • Wang G, He F, Xu Y, Zhang Y. Immunopotentiator thymosin alpha-1 promotes neurogenesis and cognition in the developing mouse via a systemic Th1Bias. Neurosci Bull. 2017 Dec;33(6):675–84.
  • Herring A, Blome M, Ambrée O, Sachser N, Paulus W, Keyvani K. Reduction of cerebral oxidative stress following environmental enrichment in mice with alzheimer-like pathology. Brain Pathol. 2010 Jan;20(1):166–75. doi:10.1111/j.1750-3639.2008.00257.x.
  • Pan Y, Short JL, Newman SA, Choy KHC, Tiwari D, Yap C, Senyschyn D, Banks WA, Nicolazzo JA. Cognitive benefits of lithium chloride in APP/PS1 mice are associated with enhanced brain clearance of β-amyloid. Brain Behav Immun. 2018 Mar 12:S0889-1591(18)30055-2.
  • Asuni AA, Boutajangout A, Quartermain D, Sigurdsson EM. Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J Neurosci. 2007;27(34):9115–29. doi:10.1523/JNEUROSCI.2361-07.2007.
  • Fadda F, Cocco S, Stancampiano R, Rossetti ZL. Long-term voluntary ethanol consumption affects neither spatial nor passive avoidance learning, nor hippocampal acetylcholine release in alcohol-preferring rats. Behav Brain Res. 1999 Aug;103(1):71–6.
  • Gonzalez B, Abud EM, Abud AM, Poon WW, Gylys KH. Tau spread, apolipoprotein E, inflammation, and more: Rapidly evolving basic science in alzheimer disease. Neurol Clin. 2017 May;35(2):175–90.
  • Li W, Li X, Xin X, Kan PC, Yan Y. MicroRNA-613 regulates the expression of brain-derived neurotrophic factor in Alzheimer's disease. Biosci Trends. 2016 Nov 15;10(5):372–7.
  • Sato A. The effect of reminiscence music therapy session on changes in depressive symptoms in elderly persons with dementia. J Music Ther. 2000;29(3):170–82.
  • Milev RV, Kellar T, Mc Lean M, Mileva V, Luthra V, Thompson S, Peever L. Multisensory stimulation for elderly with dementia: a 24-week single-blind randomized controlled pilot study. Am J Alzheimer's Dis Other Demen. 2008;23(4):372–6. doi:10.1177/1533317508316681.
  • Vorhees CV, Williams MT. Morriswater maze:procedures for assessing spatial and related forms of learning and memory. Nat Protoc. 2006;1:848–58.
  • Zhang Y, Zou J, Yang J, Yao Z. 4Abeta1-15-derived monoclonal antibody reduces more abeta burdens and neuroinflammation than homologous vaccinein APP/PS1 Mice. CurrAlzheimerRes. 2015;12(4):384–97.
  • Zhang Y, Li Q, Zou J, Zuo Z, Yao Z. Continuous vaccinations of 4Aβ1-15 induces specific fluctuation of inflammatory factors accompany with pathologic alterations alleviation in APP/PS1 mice. Hum Vaccin Immunother. 2015;11(11):2674–81.
  • Wang M, Bi W, Fan K. Ameliorating effect of Alpinia oxyphylla-Schisandra chinensis herb pair on cognitive impairment in a mouse model of Alzheimer's disease. Biomed Pharmacother. 2018 Jan;97:128–35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.